POPART'MUS Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple sclerosis

Trial Profile

POPART'MUS Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple sclerosis

Discontinued
Phase of Trial: Phase III

Latest Information Update: 18 Oct 2012

At a glance

  • Drugs Estradiol (Primary) ; Nomegestrol (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms POPARTMUS
  • Most Recent Events

    • 29 Dec 2011 Planned end date changed from 1 Jun 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 17 Sep 2010 Planned end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 21 Dec 2009 Currently, 126 patients have been enrolled and 107 have completed the protocol, as reported in the Journal of the Neurological Sciences.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top